Checkmate Pharmaceuticals, Inc.·4

Feb 1, 4:25 PM ET

Wigginton Jon Marc 4

4 · Checkmate Pharmaceuticals, Inc. · Filed Feb 1, 2022

Insider Transaction Report

Form 4
Period: 2022-01-30
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-30+20,06120,061 total
    Exercise: $2.19Exp: 2032-01-29Common Stock (20,061 underlying)
Footnotes (1)
  • [F1]This stock option shall vest 1/3 on the first anniversary of the grant date and monthly thereafter through the third anniversary of the grant date, subject to the Reporting Persons continued service through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION